2025-09-23 08:32
US FDA declines to approve Scholar Rock’s muscle weakness drug; shares fall
(Reuters) -The U.S. health regulator has declined to approve Scholar Rock’s drug for a rare neuromuscular disease citing issues at a third-party manufacturing facility, the company said on Tuesday. Shares of the drug developer were down 14% in premarket trading.…